Your browser doesn't support javascript.
loading
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Ballesteros, Alejandro; Sánchez-Torres, Ana M; López-Ilundain, Jose M; Cabrera, Bibiana; Lobo, Antonio; González-Pinto, Ana M; Díaz-Caneja, Covadonga; Corripio, Iluminada; Vieta, Eduard; de la Serna, Elena; Bobes, Julio; Usall, Judith; Contreras, Fernando; Lorente-Omeñaca, Ruth; Mezquida, Gisela; Bernardo, Miguel; Cuesta, Manuel J.
Afiliação
  • Ballesteros A; Estella Mental Health Center,Dirección de Salud Mental,Pamplona,Navarra,Spain.
  • Sánchez-Torres AM; IdiSNA,Navarra Institute for Health Research,Pamplona,Spain.
  • López-Ilundain JM; IdiSNA,Navarra Institute for Health Research,Pamplona,Spain.
  • Cabrera B; Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain.
  • Lobo A; Department of Medicine and Psychiatry,University of Zaragoza. Aragon Institute for Health Research (IIS Aragon),Zaragoza,Spain.
  • González-Pinto AM; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Díaz-Caneja C; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Corripio I; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Vieta E; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • de la Serna E; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Bobes J; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Usall J; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Contreras F; Network Centre for Biomedical Research in Mental Health (CIBERSAM),Madrid,Spain.
  • Lorente-Omeñaca R; IdiSNA,Navarra Institute for Health Research,Pamplona,Spain.
  • Mezquida G; Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain.
  • Bernardo M; Barcelona Clínic Schizophrenia Unit,Neuroscience Institute,Hospital Clínic de Barcelona,Barcelona,Spain.
  • Cuesta MJ; IdiSNA,Navarra Institute for Health Research,Pamplona,Spain.
Psychol Med ; 48(13): 2247-2256, 2018 10.
Article em En | MEDLINE | ID: mdl-29331153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Antipsicóticos / Antagonistas Colinérgicos / Disfunção Cognitiva / Inteligência Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Psychol Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Antipsicóticos / Antagonistas Colinérgicos / Disfunção Cognitiva / Inteligência Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Psychol Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha